✦ LIBER ✦

MS70 STUDY ON THE MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN MEXICO. ADVANCES OF PROJECT

✍ Scribed by Vaca, G.; Vázquez, A.; Magaña, M.T.; Ramírez, M.L.; Dávalos, I.P.; Marín, B.; Martínez, E.; Carrillo, G.

Book ID: 118638576
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 55 KB
Volume: 11
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(10)70571-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The molecular basis of familial hypercho

The molecular basis of familial hypercholesterolemia in The Netherlands

✍ Sigrid W. Fouchier; Joep C. Defesche; Marina A. Umans-Eckenhausen; John J. Kaste 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 97 KB

The molecular basis of familial hypercho

The molecular basis of familial hypercholesterolemia in the Netherlands

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Update of the molecular basis of familia

Update of the molecular basis of familial hypercholesterolemia in The Netherlands

✍ Sigrid W. Fouchier; John J.P. Kastelein; Joep C. Defesche 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Autosomal-dominant hypercholesterolemia (ADH) has been identified as a major risk factor for coronary vascular disease (CVD) and is associated with mutations in the low-density lipoprotein receptor (LDLR) and the apolipoprotein B (APOB) gene. Since 1991 DNA samples from clinically diagnosed ADH pati

3P-0741 The molecular basis of familial

3P-0741 The molecular basis of familial hypercholesterolemia in Japanese population

✍ Miyake, Y.; Yamamura, T.; Yamamoto, A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The molecular basis of familial hypercho

The molecular basis of familial hypercholesterolemia in the Czech Republic: Spectrum of LDLR mutations and genotype–phenotype correlations

✍ Lukáš Tichý; Tomáš Freiberger; Petra Zapletalová; Vladimír Soška; Barbora Ravčuk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The molecular basis of familial hypercho

The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene

✍ Marianne Abifadel; Jean-Pierre Rabès; Sélim Jambart; Georges Halaby; Marie-Hélèn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

Autosomal dominant hypercholesterolemia (ADH), a major risk for coronary heart disease, is associated with mutations in the genes encoding the low-density lipoproteins receptor (LDLR), its ligand apolipoprotein B (APOB) or PCSK9 (Proprotein Convertase Subtilin Kexin 9). Familial hypercholesterolemia